Horie and Sato (IMAGE)
Caption
Kanta Horie, PhD, (left) and Chihiro Sato, PhD, discuss data in the Tracy Family SILQ Center at Washington University School of Medicine in St. Louis. Sato and Horie led a team that discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD.
Credit
Matt Miller/Washington University
Usage Restrictions
This image is to be used in accordance with the mission, policies and guidelines of Washington University in St. Louis. Visit https://wustl.edu/about/compliance-policies/media-policies/multimedia-use/ for more information.
License
Original content